GlassScriptPhysician profile
Evan M Witherington
NPI 1205165651
$1,147.84
in general payments reported to CMS, 2019-2025
12 companies · $98.52 in 2025
The $98.52 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $101 · 2022: $166 · 2023: $106 · 2024: $676 · 2025: $98.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $880.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $432.46 | 2023-2024 | Qelbree, Qelbree |
| Corium, LLC | $229.22 | 2023-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $130.26 | 2022-2024 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $63.77 | 2021-2025 | Invega Sustenna |
| Alkermes, INC. | $62.84 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $50.13 | 2021-2022 | |
| Adlon Therapeutics L.P. | $39.33 | 2021 | |
| Noven Therapeutics, LLC | $38.30 | 2024-2025 | Secuado, Xelstrym |
| Collegium Pharmaceutical, INC. | $33.12 | 2025 | Jornay Pm |
| Otsuka America Pharmaceutical, INC. | $26.58 | 2023-2024 | Rexulti, Abilify Maintena |
| Merck Sharp & Dohme LLC | $24.23 | 2022 | |
| Neurocrine Biosciences, INC. | $17.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Witherington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.